• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Provider knowledge of trivalent inactivated and high-dose influenza vaccines

tetano

Editor, Senior Moderator
Vaccine. 2014 Sep 20. pii: S0264-410X(14)01250-X. doi: 10.1016/j.vaccine.2014.08.081. [Epub ahead of print]
Provider knowledge of trivalent inactivated and high-dose influenza vaccines.
Tewell C1, Wright PW1, Talbot HK2.
Author information
Abstract
OBJECTIVE:

The objective of this study was to assess provider knowledge about trivalent inactivated and high dose influenza vaccines. Hence, a 20-item survey was distributed to providers within the Internal Medicine department at an urban academic medical center.
RESULTS:

Two hundred and eighty-one (24.5%) providers responded. The correct response rate was 63.2%. The highest performing subspecialties were infectious diseases (80.5%), endocrinology (69.2%), and pulmonary (68%). Those who received an influenza vaccine during the most recent season scored significantly higher than those who did not (63.6% vs. 43.6%, p=.001). Areas where respondents did poorly included questions pertaining to contraindications to immunizations (27.4%), common adverse events after immunization (29.2%), target antigen (73.5%), number of strains in the trivalent inactivated vaccine (62.9%), and time to immunity (61.4%). High dose vaccine knowledge was poor, with 37% of providers unaware of its existence.
CONCLUSION:

Significant gaps in provider knowledge exist regarding both trivalent inactivated and high dose influenza vaccines.

Copyright ? 2014. Published by Elsevier Ltd.
KEYWORDS:

High dose influenza vaccine; Influenza vaccine knowledge

PMID:
25252197
[PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/25252197
 
Back
Top Bottom